Paperpal Prime Logo

The Lancet Public Health : Impact Factor & More

eISSN: 2468-2667pISSN: 2468-2667
JournalOpen Access

Key Metrics

CiteScore
39.7
Eigenfactor
0.01 - 0.05
Impact Factor
20 - 25
Scite Index
0.88 5-Year SI
SJR
Q1Public Health, Environmental and Occupational Health
SNIP
11.93
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on The Lancet Public Health

The Lancet Public Health Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher ELSEVIER SCI LTD
Language English
Frequency Monthly
Article Processing ChargesUSD 5780
Publication Time8
Editorial Review ProcessPeer review
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2016
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 8
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessPeer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in The Lancet Public Health ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in The Lancet Public Health

Prevalence of adverse childhood experience items: a systematic review and meta-analyses.
  • 1 Jul 2026
  • The Lancet. Public health
Opioid agonist treatment and risk of mortality in French primary care: a nationwide, retrospective cohort study.
  • 1 Jul 2026
  • The Lancet. Public health
The International Agency for Research on Cancer: from global evidence to national action.
  • 1 Jul 2026
  • The Lancet. Public health
Correction to Lancet Public Health 2026; 11: e375-85.
  • 1 Jul 2026
  • The Lancet. Public health
Mitigation of COVID-19 through onsite testing and education among formerly incarcerated individuals (the MOSAIC study): an open-label, single-centre, randomised controlled trial.
  • 1 Jul 2026
  • The Lancet. Public health
Paralysis in public health: evidence as an alibi?
  • 1 Jul 2026
  • The Lancet. Public health
Prevalence of adverse childhood experience items: a systematic review and meta-analyses.
  • 1 Jul 2026
  • The Lancet. Public health
Opioid agonist treatment and risk of mortality in French primary care: a nationwide, retrospective cohort study.
  • 1 Jul 2026
  • The Lancet. Public health
The International Agency for Research on Cancer: from global evidence to national action.
  • 1 Jul 2026
  • The Lancet. Public health
Correction to Lancet Public Health 2026; 11: e375-85.
  • 1 Jul 2026
  • The Lancet. Public health
Mitigation of COVID-19 through onsite testing and education among formerly incarcerated individuals (the MOSAIC study): an open-label, single-centre, randomised controlled trial.
  • 1 Jul 2026
  • The Lancet. Public health
Paralysis in public health: evidence as an alibi?
  • 1 Jul 2026
  • The Lancet. Public health

FAQs on The Lancet Public Health